Ponazuril
From Infogalactic: the planetary knowledge core
File:Ponazuril.png | |
Systematic (IUPAC) name | |
---|---|
1-Methyl-3-[3-methyl-4-[4-(trifluoromethylsulfonyl)phenoxy]phenyl]-1,3,5-triazinane-2,4,6-trione
|
|
Clinical data | |
Trade names | Marquis |
AHFS/Drugs.com | FDA Professional Drug Information |
Legal status |
|
Routes of administration |
Oral |
Identifiers | |
CAS Number | 69004-04-2 |
ATCvet code | QP51AJ04 (WHO) |
PubChem | CID: 3050408 |
ChemSpider | 2312474 |
UNII | JPW84AS66U ![]() |
Chemical data | |
Formula | C18H14F3N3O6S |
Molecular mass | 457.380 g/mol |
|
|
|
|
(verify) |
Ponazuril (INN), sold by the Bayer Corporation under the trade name Marquis, is a drug currently approved for the treatment of equine protozoal myeloencephalitis (EPM) in horses, caused by Sarcocystis neurona.[1][2] More recently, veterinarians have been preparing a formulary version of the medication for use in small animals such as cats and dogs against coccidia, an intestinal parasite. Coccidia treatment is far shorter than treatment for EPM.
See also
References
- ↑ Marquis FDA Professional Drug Information
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Equine medications
- Phenol ethers
- Sulfones
- Organofluorides
- Antiinfective agent stubs
- Veterinary medicine stubs